APOE and progression of AD–combining clinical and research data

Waleed Fawzi, Gayan Perera, Mizanur Khondoker, Tatjana Boitsova, Gerome Breen, Robert Stewart

Research output: Contribution to conferenceAbstract

Abstract

Cognitive decline in Alzheimer’s disease (AD) is inevitable, but the rate of this decline varies markedly between patients. Identifying a marker for the rate-of-decline can help in predicting prognosis and allocating resources and charting the course of care with patients and their families. Apolipoprotein E gene (APOE) is an important risk factor for late-onset AD and the presence of the genotype is the most significant genetic risk factor. However, establishing a role for APOE in predicting the rate of decline has proved elusive.
Original languageEnglish
Pages719-720
Number of pages2
DOIs
Publication statusPublished - Mar 2014
Event6th International Conference on Alzheimers Disease and Related Disorders in the Middle East - Istanbul, Turkey
Duration: 25 Oct 201327 Oct 2013

Conference

Conference6th International Conference on Alzheimers Disease and Related Disorders in the Middle East
CountryTurkey
Period25/10/1327/10/13

Cite this